Provided by Tiger Trade Technology Pte. Ltd.

Heron Therapeutics

0.3135
+0.00752.45%
Post-market: 0.32000.0065+2.07%19:54 EDT
Volume:2.47M
Turnover:800.86K
Market Cap:59.25M
PE:-1.70
High:0.3429
Open:0.3068
Low:0.3000
Close:0.3060
52wk High:1.58
52wk Low:0.2610
Shares:189.00M
Float Shares:147.00M
Volume Ratio:1.42
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1842
EPS(LYR):-0.1211
ROE:-2408.88%
ROA:-2.80%
PB:10.11
PE(LYR):-2.59

Loading ...

Heron Therapeutics Expands U.S. Portfolio Through Licensing Deal

TIPRANKS
·
Yesterday

Heron Therapeutics enters license agreement with Long Grove, Capstone

TIPRANKS
·
Yesterday

Heron Therapeutics - Granted Exclusive License to Market Products in U.S. - SEC Filing

THOMSON REUTERS
·
Yesterday

Heron Therapeutics - License Agreement Has Initial Ten-Year Term with Automatic Two-Year Renewals - SEC Filing

THOMSON REUTERS
·
Yesterday

Heron Therapeutics - Enters Multi-Product Development and License Agreement on Sept 23, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

Heron Therapeutics Signs US Multi-Product Development, License Deal with Long Grove Pharmaceuticals

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Heron Therapeutics (HRTX)

TIPRANKS
·
Aug 18

Allstate, CHMI, HRTX, AppLovin, BCE Trending With Analysts

TIPRANKS
·
Aug 15

Seer Q2 Revenue Falls 23% as Funding Slows

Reuters
·
Aug 12

HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy

MT Newswires Live
·
Aug 11

Xtant Medical Q2 Revenue Falls on Asset Sales and Lost License Revenue

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

Heron Therapeutics Inc : H.c. Wainwright Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 11

Heron Therapeutics Faces Nasdaq Delisting Risk as Share Price Falls Below $1 Threshold

TIPRANKS
·
Aug 11

TELA Bio Q2 Revenue Falls on Lower OviTex PRS Volumes, Withdraws Outlook

Reuters
·
Aug 11

Harrow Q2 Revenue Slightly Beats Estimates

Reuters
·
Aug 11

Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow

Reuters
·
Aug 11

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Aug 11

Heron Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10